Key result
Normal-weight central obesity linked to ~229% higher hypertension risk in Indigenous Australian females.
Why the study?
Cardiometabolic disorders are the leading cause of mortality in First Nations Australians, prompting investigation into factors associated with central obesity and its link to cardiometabolic disorders in normal-weight individuals.
Is normal-weight central obesity associated with an increased risk of cardiometabolic disorders among Aboriginal and Torres Strait Islander Australians?
Cross-Sectional (n=4,864)
Is normal-weight central obesity associated with an increased risk of cardiometabolic disorders among Aboriginal and Torres Strait Islander Australians?
Normal-weight central obesity is prevalent among Indigenous Australians and is significantly associated with increased risks of cardiometabolic disorders, highlighting the inadequacy of relying solely on BMI for risk assessment.
Answers are grounded in this paper and cite their sources.
Normal-weight central obesity may flag hypertension risk in women; this observational link leaves open causality and needs prospective validation.
BACKGROUND: Cardiometabolic disorders are the leading cause of mortality and contribute substantially to the First Nations Health Gap in Australia. Central obesity is the major contributor to metabolic syndrome. We investigated factors associated with central obesity and how normal-weight central obesity is associated with cardiometabolic disorders among Aboriginal and Torres Strait Islander Australians (hereafter respectfully referred to as 'Indigenous Australians'). METHODS: This study used the 2018-2019 Australian Bureau of Statistics (ABS) National Aboriginal and Torres Strait Islander Health Survey dataset. A total of weighted 4864 Indigenous adults (18 + years) were included. Normal-weight central obesity refers to individuals with a normal body mass index (BMI) but with an elevated waist circumference (WC ≥ 102 cm for males and ≥ 88 cm for females). Main outcomes included self-reported type 2 diabetes, hypertension, high cholesterol and heart disease. Multi-level logistic regression models were used to examine the relationship between explanatory variables and outcomes. RESULTS: The overall prevalence of central obesity was 46.2% (95% confidence interval [CI]: 42.8, 49.72) in males and 67.7% (95% CI: 64.90, 70.4) in females. Physical inactivity increased the risk of central obesity in males (odds ratio [OR] = 1.34; 95% CI: 1.09, 1.65), while daily consumption of soft drinks was associated with central obesity in females (OR = 1.35; 95% CI: 1.12, 1.62). Males living in very remote areas had a lower risk of central obesity, while females in very remote areas had a higher risk. Our findings also showed that females with normal-weight central obesity had a higher risk of hypertension (OR = 3.29; 95% CI: 1.95, 9.62) and higher total cholesterol (OR = 4.62; 95% CI: 2.22, 9.62). Similarly, males with normal-weight central obesity were associated with a higher risk of type 2 diabetes (OR = 4.13; 95% CI: 1.23, 13.94). CONCLUSIONS: This was the first study to report that approximately 12% of Indigenous Australians with normal BMI have central obesity. Relying solely on BMI to identify such high-risk individuals may be inadequate for early intervention. Public health initiatives targeting obesity should include individuals with a normal BMI and central obesity.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) conducted a cross-sectional in Cardiometabolic disorders (n=4,864). Normal-weight central obesity vs. Normal BMI without central obesity was evaluated on Hypertension (in females) (OR 3.29, 95% CI 1.95, 9.62). Normal-weight central obesity in Indigenous Australians was associated with a higher risk of hypertension and high cholesterol in females, and type 2 diabetes in males.
Synapse has enriched 10 related papers. Consider them for comparative context: